Increase/Decrease in Cash: The total change in cash for the company over the given period.
Astellas Pharma Inc. (ALPMY) had Increase/Decrease in Cash of $428.51M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$9.37B |
|
$2.29B |
|
$14.06B |
|
$23.43B |
|
$8.61B |
|
$2.68B |
|
$3.34B |
|
$11.95B |
|
$11.47B |
|
$1.80B |
|
$11.47B |
|
-- |
|
| Cash Flow Statement Financials | |
$2.32B |
|
$-298.87M |
|
$-1.60B |
|
$1.22B |
|
$1.65B |
|
|
Increase/Decrease in Cash |
$428.51M |
-- |
|
$-884.64M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|